Document:

<PAGE>
                                                                   EXHIBIT 10.27

                           ALTUS PHARMACEUTICALS INC.
                   EXECUTIVE OFFICER COMPENSATION INFORMATION

The Compensation Committee of the Board of Directors (the "Compensation
Committee") of Altus Pharmaceuticals Inc. ("Altus") has approved the 2005 fiscal
year cash bonuses and 2006 fiscal year annual base salaries, effective as of
January 1, 2006, of Altus' Chief Executive Officer and its four other most
highly compensated executive officers who were employed by us as of December 31,
2005 and earned more than $100,000 in salary and bonus for the year ended
December 31, 2005 (the "named executive officers").

<TABLE>
<CAPTION>
Name and Position                           2005 Base Salary ($)      2006 Base Salary ($)       2005 Bonus ($)    2006 Bonus ($)
-----------------                           --------------------      --------------------       --------------    --------------
<S>                                         <C>                       <C>                        <C>               <C>
Sheldon Berkle                                    400,000                   412,000                 153,000             (1)
President and Chief Executive Officer

Don G. Burstyn, Ph.D.                             256,875                   269,462                 25,000              (1)
Vice President, Regulatory Affairs and
Quality Assurance

Robert Gallotto                                   210,000                   240,000                 38,000              (1)
Vice President, Strategic Planning and
Alliance Management

Jonathan I. Lieber                                206,000                   250,000                 38,000              (1)
Vice President, Chief Financial Officer
and Treasurer

Alexey L. Margolin, Ph.D.                         271,282                   286,203                 67,000              (1)
Chief Scientific Officer
</TABLE>

      The 2005 fiscal year cash bonuses for Altus' Chief Executive Officer and
the named executive officers was determined by the Compensation Committee based
upon overall corporate performance together with a subjective assessment by the
Compensation Committee of each officer's achievement of previously established
performance goals which relate to the officer's areas of responsibility.

      (1) For the 2006 fiscal year, the named executive officers are eligible to
receive a cash bonus of up to 20% of their base salary, except for Altus' Chief
Executive Officer,
<PAGE>
who is eligible to receive a cash bonus of up to 50% of his base salary, upon
the achievement of individual performance goals.

      In addition, on January 9, 2006, the Compensation Committee granted
options to the named executive officers to purchase shares of Altus' common
stock, $.01 par value per share, each at an exercise price of $11.47 per share,
as follows: Sheldon Berkle received an option to purchase 26,166 shares; Don G.
Burstyn, Ph.D., received an option to purchase 15,262 shares; Robert Gallotto
received an option to purchase 27,890 shares; Jonathan I. Lieber received an
option to purchase 26,488 shares; and Alexey L. Margolin received an option to
purchase 26,954 shares. Each of such options has a term of ten years vesting
over four years, with 1/16th of the options vesting every three months. These
numbers have been adjusted to reflect the 1-for-2.293 reverse stock split that
took effect in January 2006.

      Further information with respect to the compensation of Altus' named
executive officers is set forth in the Registration Statement on Form S-1 (File
No. 333-129037).<PAGE>

                                                                   EXHIBIT 10.28

                           ALTUS PHARMACEUTICALS INC.
                          DIRECTOR COMPENSATION POLICY

         The Compensation Committee of the Board of Directors of Altus
Pharmaceuticals Inc. (the "Company") has approved the following policy which
establishes compensation to be paid to non-employee directors of the Company,
effective as of the closing of the Company's initial public offering (the
"Effective Time"), to provide an inducement to obtain and retain the services of
qualified persons to serve as members of the Company's Board of Directors. All
stock option amounts set forth herein shall be subject to automatic adjustment
in the event of any stock split or other recapitalization affecting the
Company's common stock following the Effective Time.

APPLICABLE PERSONS

         This Policy shall apply to each director of the Company who is not an
employee of, or compensated consultant to, the Company or any Affiliate, unless
such compensation is received solely for services provided as a member of the
Scientific Advisory Board (each, an "Outside Director"). Affiliate shall mean a
corporation which is a direct or indirect parent or subsidiary of the Company,
as determined pursuant to Section 424 of the Internal Revenue Code of 1986, as
amended.

STOCK OPTION GRANTS

         Annual Grants

         Each Outside Director shall annually be granted a non-qualified stock
option to purchase 8,722 shares of the Company's common stock under the
Company's Amended and Restated 2002 Employee, Director and Consultant Stock Plan
(the "Stock Plan") at the annual meeting of the Board of Directors following the
Company's annual meeting of stockholders; provided that if there has been no
annual meeting of stockholders held by the first day of the third fiscal quarter
of the year in which the Effective Time occurs, each Outside Director will still
receive any annual grants of non-qualified stock options provided for under this
policy on the first day of the third fiscal quarter of the year; and provided
further, that if an annual meeting of stockholders is subsequently held during
the year in which the Effective Time occurs, no additional annual grant shall be
made. Unless otherwise specified by the Board or the Compensation Committee at
the time of grant, all options granted under this policy shall (i) vest
quarterly over four years, subject to the Outside Director's continued service
on the Board; provided that such options shall become exercisable in full
immediately prior to a change in control of the Company, (ii) have an exercise
price equal to the fair market value of the Company's common stock as determined
in the Stock Plan, and (iii) contain such other terms and conditions as the
Board or the Compensation Committee shall determine; and provided, further,
however, that any options granted under this policy on or before the first day
of the third fiscal quarter of 2006 to any Outside Director who was serving as
an Outside Director as of the Effective Time shall vest quarterly over four
years, and such vesting shall commence as of January 1, 2006.

<PAGE>

         Initial Grant For Newly Appointed or Elected Directors

         Each new Outside Director on the date of his or her initial appointment
or election to the Board of Directors shall be granted a non-qualified stock
option to purchase 17,444 shares of the Company's common stock under the Stock
Plan.

ANNUAL CASH FEE

         Each Outside Director shall be compensated on an annual basis for
providing services to the Company. Each Outside Director shall receive an annual
fee of $20,000.

         Cash Payments

         Cash payments to be paid to an Outside Director shall be paid quarterly
in arrears as of the last day of each calendar quarter. If an Outside Director
dies, resigns or is removed during any quarter, he or she shall be entitled to a
cash payment on a pro rata basis through his or her last day of service.

         Initial Fee Upon Institution of Policy

         On the last day of the first fiscal quarter following the Effective
Time, each Outside Director then serving shall be paid his or her quarterly cash
compensation prorated for the period from January 1, 2006 through such date.
Thereafter, quarterly cash payments shall be made in accordance with this
policy.

         Initial Fee For Newly Appointed or Elected Directors

         On the last day of the first fiscal quarter following an Outside
Director's first election or appointment to the Board of Directors after the
Effective Time, such Outside Director shall receive his or her quarterly cash
compensation prorated in accordance with the terms of this Policy from the
beginning of the calendar quarter in which he or she was initially appointed or
elected and payable as set forth above.

                                       2

<PAGE>

BOARD COMMITTEE COMPENSATION

         Each Outside Director shall also receive an annual fee of $5,000 for
each committee of the Board of Directors on which such individual serves (if not
serving as Chairman of such committee) and a non-qualified stock option grant
under the Stock Plan to purchase 2,181 shares of the Company's common stock upon
election to such committee and an annual grant of non-qualified stock options to
purchase 1,090 shares of the Company's common stock each year thereafter.
However, the Chairman of each Committee, other than the Audit Committee, shall
receive an annual fee of $10,000 and a non-qualified stock option grant under
the Stock Plan to purchase 4,361 shares of the Company's common stock upon
election as Chairman of such committee and an annual grant of non-qualified
stock options to purchase 2,181 shares of the Company's common stock each year
thereafter. The Chairman of the Audit Committee shall receive an annual fee of
$12,500 for services as Chairman and a non-qualified stock option grant under
the Stock Plan to purchase 4,361 shares of the Company's common stock upon
election of Chairman of such committee and an annual grant of non-qualified
stock options to purchase 2,181 shares of the Company's common stock each year
thereafter.

EXPENSES

         Upon presentation of documentation of such expenses reasonably
satisfactory to the Company, each Outside Director shall be reimbursed for his
or her reasonable out-of-pocket business expenses incurred in connection with
attending meetings of the Board of Directors, Committees thereof or in
connection with other Board related business.

AMENDMENTS

         The Compensation Committee or the Board of Directors shall review this
Policy from time to time to assess whether any amendments in the type and amount
of compensation provided herein should be adjusted in order to fulfill the
objectives of this Policy.

DATED:  January 9, 2006

                                        3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]